These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10369274)

  • 61. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
    Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.
    Del Rey J; Prat E; Ponsa I; Lloreta J; Gelabert A; Algaba F; Camps J; Miró R
    BMC Cancer; 2010 Jun; 10():280. PubMed ID: 20540739
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
    Utikal J; Udart M; Leiter U; Peter RU; Krähn G
    Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double-target fluorescence in situ hybridization distinguishes multiple genetically aberrant clones in head and neck squamous cell carcinoma.
    Veltman JA; Hopman AH; van der Vlies SA; Bot FJ; Ramaekers FC; Manni JJ
    Cytometry; 1998 Jun; 34(3):113-20. PubMed ID: 9696155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis.
    Ruiz C; Martins JR; Rudin F; Schneider S; Dietsche T; Fischer CA; Tornillo L; Terracciano LM; Schreiber R; Bubendorf L; Kunzelmann K
    PLoS One; 2012; 7(8):e43265. PubMed ID: 22912841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.
    Rodrigo JP; Menéndez ST; Hermida-Prado F; Álvarez-Teijeiro S; Villaronga MÁ; Alonso-Durán L; Vallina A; Martínez-Camblor P; Astudillo A; Suárez C; María García-Pedrero J
    Sci Rep; 2015 Oct; 5():15698. PubMed ID: 26498851
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.
    Martin CL; Reshmi SC; Ried T; Gottberg W; Wilson JW; Reddy JK; Khanna P; Johnson JT; Myers EN; Gollin SM
    Oral Oncol; 2008 Apr; 44(4):369-82. PubMed ID: 17681875
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
    Tanner MM; Karhu RA; Nupponen NN; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola JJ
    Am J Pathol; 1998 Jul; 153(1):191-9. PubMed ID: 9665480
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization.
    Juhász A; Balázs M; Sziklay I; Rákosy Z; Treszl A; Répássy G; Adány R
    Cytometry A; 2005 Oct; 67(2):151-60. PubMed ID: 16163698
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.
    Clark ES; Brown B; Whigham AS; Kochaishvili A; Yarbrough WG; Weaver AM
    Oncogene; 2009 Jan; 28(3):431-44. PubMed ID: 18931703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
    Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I
    Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fluorescent in situ hybridisation (FISH) characterisation of pericentromeric breakpoints on chromosome 5 in head and neck squamous cell carcinomas.
    Martins C; Jin Y; Jin C; Wennerberg J; Höglund M; Mertens F
    Eur J Cancer; 1999 Mar; 35(3):498-501. PubMed ID: 10448306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
    Gibcus JH; Kok K; Menkema L; Hermsen MA; Mastik M; Kluin PM; van der Wal JE; Schuuring E
    Hum Genet; 2007 Apr; 121(2):187-201. PubMed ID: 17171571
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
    Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
    Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.
    Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD
    Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.